Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urine-based antigen detection assay for diagnosis of visceral leishmaniasis using monoclonal antibodies specific for six protein biomarkers of Leishmania infantum / Leishmania donovani.
Abeijon C, Alves F, Monnerat S, Mbui J, Viana AG, Almeida RM, Bueno LL, Fujiwara RT, Campos-Neto A. Abeijon C, et al. Among authors: campos neto a. PLoS Negl Trop Dis. 2020 Apr 23;14(4):e0008246. doi: 10.1371/journal.pntd.0008246. eCollection 2020 Apr. PLoS Negl Trop Dis. 2020. PMID: 32324742 Free PMC article.
Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.
Fujiwara RT, Vale AM, França da Silva JC, da Costa RT, Quetz Jda S, Martins Filho OA, Reis AB, Corrêa Oliveira R, Machado-Coelho GL, Bueno LL, Bethony JM, Frank G, Nascimento E, Genaro O, Mayrink W, Reed S, Campos-Neto A. Fujiwara RT, et al. Vet Res. 2005 Sep-Dec;36(5-6):827-38. doi: 10.1051/vetres:2005033. Vet Res. 2005. PMID: 16120256 Free article.
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
Miret J, Nascimento E, Sampaio W, França JC, Fujiwara RT, Vale A, Dias ES, Vieira E, da Costa RT, Mayrink W, Campos Neto A, Reed S. Miret J, et al. Vaccine. 2008 Mar 17;26(12):1585-94. doi: 10.1016/j.vaccine.2008.01.026. Epub 2008 Feb 4. Vaccine. 2008. PMID: 18328956 Free PMC article.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.
Nascimento E, Fernandes DF, Vieira EP, Campos-Neto A, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Pine SO, Cowgill KD, Reed SG, Piazza FM. Nascimento E, et al. Vaccine. 2010 Sep 14;28(40):6581-7. doi: 10.1016/j.vaccine.2010.07.063. Epub 2010 Aug 3. Vaccine. 2010. PMID: 20688040 Clinical Trial.
Vaccines for the leishmaniases: proposals for a research agenda.
Working Group on Research Priorities for Development of Leishmaniasis Vaccines; Costa CH, Peters NC, Maruyama SR, de Brito EC Jr, Santos IK. Working Group on Research Priorities for Development of Leishmaniasis Vaccines, et al. PLoS Negl Trop Dis. 2011 Mar 29;5(3):e943. doi: 10.1371/journal.pntd.0000943. PLoS Negl Trop Dis. 2011. PMID: 21468307 Free PMC article. No abstract available.
117 results